Orthorebirth Co., Ltd.
ORTHOREBIRTH is a pioneering company in regenerative medicine, specializing in innovative synthetic bone-void-filling materials and microfiber technology. Their flagship product, ReBOSSIS, is a flexible, cottony artificial bone designed to promote bone regeneration and is used in orthopedic surgeries worldwide. The company is committed to advancing regenerative medicine through research, development, and strategic partnerships.
Industries
Nr. of Employees
small (1-50)
Orthorebirth Co., Ltd.
15-3-303 Chigasaki-Chuo, Tsuzuki-ku, Yokohama-shi Kanagawa pref., Japan 224-0032
Patents
Method for manufacturing bone-regeneration material comprising biodegradable fibers by using electrospinning method
US-11969521-B2
View DetailsMethod for manufacturing bone-regeneration material comprising biodegradable fibers by using electrospinning method
US-10646616-B2
View Details
Method for manufacturing bone-regeneration material comprising biodegradable fibers by using electrospinning method
US-11969521-B2
View DetailsMethod for manufacturing bone-regeneration material comprising biodegradable fibers by using electrospinning method
US-10646616-B2
View DetailsProducts
Cottony bioabsorbable bone-void-filling material
Flexible, soft, cotton-like bone void filler intended to be bioabsorbed and gradually replaced by host bone; designed for adaptable handling and variable filling volumes for bone defects.
Microfiber-based stem cell culture and implantable sheet (research use)
Microfiber sheet for stem cell culture that accelerates cell proliferation and is designed to be implantable without removing the sheet; offered for research purposes.
Hybrid bone-regeneration composite (β-TCP-containing) — under development
Hybrid material combining microfiber scaffold and protein components with β-tricalcium phosphate aimed at promoting bone regeneration; described as a development-stage medicine.
Biomaterial-based local drug-delivery prototype
Concept and research prototypes where therapeutics are kneaded into cottony/microfibrous materials for local application to affected areas.
Cottony bioabsorbable bone-void-filling material
Flexible, soft, cotton-like bone void filler intended to be bioabsorbed and gradually replaced by host bone; designed for adaptable handling and variable filling volumes for bone defects.
Microfiber-based stem cell culture and implantable sheet (research use)
Microfiber sheet for stem cell culture that accelerates cell proliferation and is designed to be implantable without removing the sheet; offered for research purposes.
Hybrid bone-regeneration composite (β-TCP-containing) — under development
Hybrid material combining microfiber scaffold and protein components with β-tricalcium phosphate aimed at promoting bone regeneration; described as a development-stage medicine.
Biomaterial-based local drug-delivery prototype
Concept and research prototypes where therapeutics are kneaded into cottony/microfibrous materials for local application to affected areas.
Services
Joint R&D projects with universities and institutions including subsidized development work and technology transfer for regenerative-medicine products.
Commercial distribution and market-entry support for absorbable biomaterial products across territories.
Joint R&D projects with universities and institutions including subsidized development work and technology transfer for regenerative-medicine products.
Commercial distribution and market-entry support for absorbable biomaterial products across territories.
Expertise Areas
- Regenerative medicine
- Biomaterials and scaffold engineering
- Bone graft substitute development
- Cell culture technologies for implantation
Key Technologies
- Microfiber fabrication for biomaterials
- Bioabsorbable scaffold engineering
- Beta-tricalcium phosphate (β-TCP) composites
- Implantable cell-culture sheets
News & Updates
Participation in the AAOS2023 event to showcase products.
Launch of ReBOSSIS-J in Japan by Teijin Nakashima Medical.
Official start of sales for ReBOSSIS-J in Japan.
Regulatory approval for ReBOSSIS-J in Japan.
Participation in the AAOS2023 event to showcase products.
Launch of ReBOSSIS-J in Japan by Teijin Nakashima Medical.
Official start of sales for ReBOSSIS-J in Japan.
Regulatory approval for ReBOSSIS-J in Japan.